Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
IONS
Why Does Ionis Pharmaceuticals (IONS) Have a Good Analyst Rating?
| 2024-06-24 |
PHARMACEUTICAL
Ionis Pharmaceuticals Expands Licensing Agreement with Otsuka for Hereditary Angioedema Treatment
| 2024-06-18 |
PHARMACEUTICAL
What Are the Tailwinds for IONS?
| 2023-04-18 |
PHARMACEUTICAL
